Lyell Immunopharma Growth Metrics (2020-2025) | LYEL

Growth Metrics Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -0.01M0.16M-0.13M-1.10M0.23M-239.49M0.30M-8.41M-23.10M219.80M-39.88M-193.53M-12.12M7.09M-135.03M128.50M-18.25M-13.03M
EBITDA Margin Growth (3y) -22.88M-19.52M-39.71M-203.03M-34.99M-12.59M-174.61M-73.43M-53.47M213.86M
EBITDA Margin Growth (5y) -53.25M-25.46M
EBITDA Margin (QoQ) -0.11M0.17M-0.06M-0.01M0.06M-0.12M-1.02M1.31M-239.65M239.66M-9.73M-13.38M3.25M-20.02M-163.38M168.02M22.46M-162.14M100.16M21.27M27.68M
EBIT Margin Growth (1y) 0.02M0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M
EBIT Margin Growth (3y) -24.15M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M
EBIT Margin Growth (5y) -58.66M-24.49M
EBIT Margin (QoQ) -0.08M0.17M-0.06M-0.01M0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M
EBT Margin Growth (1y) 0.01M0.16M955.00-1.01M0.23M-213.78M0.16M-7.70M-22.45M192.98M-40.32M-153.59M-12.28M7.87M-138.06M86.08M-20.09M-9.56M
EBT Margin Growth (3y) -22.22M-20.64M-40.16M-162.29M-34.50M-12.92M-178.22M-75.20M-54.82M191.30M
EBT Margin Growth (5y) -54.59M-22.32M
EBT Margin (QoQ) -0.09M0.17M-0.06M-0.01M0.06M0.01M-1.07M1.22M-213.94M213.95M-8.93M-13.53M1.49M-19.35M-122.19M127.78M21.64M-165.29M101.95M21.61M32.17M
Enterprise Value Growth (1y) -533.70%1,152.72%2,268.00%303.46%355.88%-63.41%-60.04%-81.95%-103.79%-79.14%-117.67%-22.04%270.25%-165.73%57.73%-209.36%-452.91%-12.37%91.25%
Enterprise Value Growth (3y) 62.96%41.01%-15.24%31.74%29.37%-27.04%-26.62%-29.14%-30.60%-29.15%-26.13%
Enterprise Value Growth (5y) -14.69%9.91%43.69%
Enterprise Value (QoQ) 45.26%-354.20%60.11%1,161.54%12.72%-57.37%-49.83%51.81%23.09%-80.74%-110.53%935.79%-204.25%184.98%-77.01%-422.69%32.95%-119.83%25.80%-2.74%94.78%
FCF Margin Growth (1y) 0.19M0.07M-0.83M0.21M-132.85M0.14M-6.30M-14.84M117.83M-31.27M-133.44M-14.56M4.83M-11.71M62.24M-13.87M-8.77M
FCF Margin Growth (3y) -14.83M-31.05M-140.57M-29.19M-10.19M-42.83M-77.51M-43.27M113.89M
FCF Margin Growth (5y) -18.77M
FCF Margin (QoQ) 0.10M0.01M-0.01M0.09M-0.02M-0.89M1.03M-132.97M132.97M-7.34M-7.50M-0.30M-16.12M-109.51M111.38M19.09M-32.66M-35.56M35.27M24.19M
Net Margin Growth (1y) 0.01M0.16M955.00-1.01M0.23M-213.78M0.16M-7.70M-22.45M192.98M-40.32M-153.59M-12.28M7.87M-138.06M86.08M-20.09M-9.56M
Net Margin Growth (3y) -22.22M-20.64M-40.16M-162.29M-34.50M-12.92M-178.22M-75.20M-54.82M191.30M
Net Margin Growth (5y) -54.59M-22.32M
Net Margin (QoQ) -0.09M0.17M-0.06M-0.01M0.06M0.01M-1.07M1.22M-213.94M213.95M-8.93M-13.53M1.49M-19.35M-122.19M127.78M21.64M-165.29M101.95M21.61M32.17M
Operating Margin Growth (1y) 0.02M0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M
Operating Margin Growth (3y) -24.15M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M
Operating Margin Growth (5y) -58.66M-24.49M
Operating Margin (QoQ) -0.08M0.17M-0.06M-0.01M0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M
Return on Assets Growth (1y) -5.000.00M2.00-3.00-1.00-10.00-11.00-7.00-8.00-31.00-44.00-53.00-53.00
Return on Assets Growth (3y) -13.00-42.00-53.00-64.00-61.00
Return on Assets (QoQ) -1.00-2.001.00-2.003.000.00M-4.000.00M-7.00-1.000.00M0.00M-30.00-13.00-9.000.00M
Return on Capital Employed Growth (1y) -5.00-1.001.00-5.00-3.00-13.00-14.00-10.00-10.00-38.00-51.00-61.00-58.00
Return on Capital Employed Growth (3y) -18.00-52.00-65.00-76.00-71.00
Return on Capital Employed (QoQ) -1.00-2.001.00-3.003.000.00M-5.000.00M-8.00-1.000.00M-1.00-36.00-14.00-10.002.00
Return on Equity Growth (1y) -76.0033.00-5.001.004.00-3.000.00M-11.00-13.00-8.00-9.00-40.00-60.00-72.00-70.00
Return on Equity Growth (3y) -85.0022.00-14.00-51.00-69.00-83.00-79.00
Return on Equity (QoQ) -107.0035.00-2.00-3.002.00-3.004.001.00-5.000.00M-8.00-1.000.00M-1.00-38.00-21.00-12.002.00
Return on Sales Growth (1y) -326.000.00M0.00M0.00M0.00M78.00176.00
Return on Sales (QoQ) -9.00248.0019.00-584.000.00M-73.00339.0011.00-199.0024.00